Companies / Elevation Oncology, Inc.
Elevation Oncology, Inc.
ELEVCIK 1783032
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | venBio Global Strategic Fund III, L.P. 10% owner | Buy Open-market buy | Common Stock | $10.00M | +625K +31.52% | 2,608,167 | high |
| Jun 29, 2021 | Qiming U.S. Healthcare Fund II, L.P. 10% owner | Buy Open-market buy | Common Stock | $5.00M | +313K +15.19% | 2,370,142 | high |
| Jun 29, 2021 | Vertex Global HC Fund II Pte. Ltd. 10% owner | Buy Open-market buy | Common Stock | $4.00M | +250K +12.15% | 2,307,642 | high |
| Jun 29, 2021 | Cormorant Asset Management, LP 10% owner | Buy Open-market buy | Common Stock | $4.00M | +250K +12.61% | 2,233,168 | high |
| Jun 29, 2021 | Aisling Capital IV, LP 10% owner | Buy Open-market buy | Common Stock | $3.00M | +188K +7.08% | 2,834,910 | high |
| May 25, 2022 | venBio Global Strategic Fund III, L.P. 10% owner | Sell Open-market sale | Common Stock | $2.90M | -703K -26.94% | 1,905,430 | medium |
| Jun 16, 2022 | Ferra Joseph J Jr Executive | Other Withheld for taxes | Common Stock | $24.1K | -19K -38.00% | 31,154 | low |
| Mar 16, 2024 | Ferra Joseph J Jr Executive | Other Withheld for taxes | Common Stock | $21.0K | -5K -5.28% | 85,680 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ELEV | common | 28623U101 |